Research Article
The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure
Table 4
Baseline characteristics of good and bad outcome patient groups.
| | | Good outcome | Number of cases | Bad outcome | Number of cases | value |
| | Age (years) | 49.72 ± 9.57 | 32 | 44.24 ± 11.98 | 25 | 0,08 | | Sex | F: 7 (22%)
M: 25 (80%) | 32 | F: 5 (20%)
M: 20 (80%) | 25 | 0,863 | | NYHA functional class | I: 1 (3.3%)
II: 4 (13.3%)
III: 22 (73.3%)
IV: 3 (10.1%) | | I: 0
II: 1 (4%)
III: 16 (64%)
IV: 8 (32%) | | 0,119 | | Inflammatory infiltrates in myocardium | Inflammatory DCM
Noninflammatory DCM | 15 (51.7%)
14 (48.3%) | | 15 (60%)
10 (40%) | 0,541 | | BMI (kg/m2) | 27.96 ± 5.57 | 32 | 27.06 ± 5.17 | 25 | 0.51 | | GFR (ml/min) | 108.4 ± 33.83 | 29 | 117.98 ± 31.38 | 25 | 0.30 | | Systolic BP (mmHg) | 124 ± 21 | 32 | 106 ± 15 | 25 | 0.0002 | | Diastolic BP (mmHg) | 80 ± 13 | 32 | 70 ± 15 | 25 | 0.01 | | Serum glucose (mmol/l) | 5.45 ± 1.49 | 19 | 4.94 ± 1.25 | 15 | 0.093 | | (ug/ml) | 10.9 ± 17.87 | 32 | 23.4 ± 23.1 | 23 | 0.01 | | (pg/ml) | 228 ± 915.4 | 31 | 1397.1 ± 2500.75 | 25 | 0.004 | | IL- (pg/ml) | 2.01 ± 2.36 | 32 | 5.45 ± 12.29 | 23 | 0.002 | | TNF- (pg/ml) | 8.2 ± 3.71 | 32 | 8.74 ± 4.73 | 23 | 0.239 | | CRP (ug/ml) | 3.25 ± 15.73 | 28 | 6.55 ± 14.13 | 24 | 0.388 | | (pg/ml) | 24.67 ± 27.8 | 32 | 32.98 ± 44.3 | 23 | 0.167 | | LVEDD (cm) | 6.65 ± 0,67 | 32 | 7.09 ± 0.9 | 25 | 0.062 | | LVEF (%) | 29.45 ± 9.9 | 32 | 22.56 ± 7.0 | 25 | 0.005 | | Average global strain (%) | −10.11 ± 2.87 | 23 | −5.46 ± 2.30 | 18 | 0.001 | | Mean (mmHg) | 9.00 ± 7.0 | 31 | 13.00 ± 15.5 | 20 | 0.016 | | Mean (mmHg) | 24.0 ± 16.0 | 31 | 35.5 ± 16.75 | 22 | 0.021 | | Mean PCWP (mmHg) | 19.7 ± 7.56 | 31 | 25.36 ± 9.9 | 22 | 0.03 | | CD3+ (cells/mm2) | 10 ± 5 | 30 | 10 ± 11 | 25 | 0.249 | | CD45ro+ (cells/mm2) | 7 ± 4 | 30 | 7 ± 7 | 25 | 0.574 | | CD68+ (cells/mm2) | 5 ± 2 | 30 | 3 ± 2 | 25 | 0.716 | | CO (ml/min) | 4.47 ± 1.26 | 29 | 3.51 ± 1.94 | 22 | 0.049 | | CI (ml/min/m2) | 2.09 ± 0.71 | 30 | 1.79 ± 0.80 | 21 | 0.036 |
|
|
BMI: body mass index, GFR: glomerular filtration rate, systolic BP: systolic blood pressure, diastolic BP: diastolic blood pressure, APN: adiponectin, BNP: B-type natriuretic peptide, IL-6: interleukin-6, TNF-α: tumor necrosis factor α, CRP: C reactive protein, TnT: hs troponin T, LVEF: left ventricular ejection fraction, LVEDD: left ventricle diastolic diameter, RAP: right atrial pressure, PAP: pulmonary artery pressure, PCWP: pulmonary capillary wedge pressure, CD3+: T cell receptor, CD45ro+: memory T cell receptor, CD68+: monocyte/macrophage receptor, CO: cardiac output, and CI: cardiac index; significant values are bolded. Significant at the level 0.05 (2-tailed). Median ± interquartile range.
|
